Delivery Order SPE2DR25D1017-SPE2DR26F9CCN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,521.56 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, represents a routine pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, executed performance from its...
- The Defense Logistics Agency awarded a $26,282.34 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets (30-count units). This is a firm fixed-price contract with an ultimate completion date of January 2, 2026, and no set-aside designation was utilized in the award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor fulfilling this order under its broader...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-unit package) valued at $1,460.13 under a firm fixed price contract. This delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order as a child contract under its larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a ceiling value of $1,385.52. This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive, non-set-aside contract has a ceiling value of $1,460.13 and is scheduled for completion by January 2, 2026. The order is priced on a firm fixed-price basis and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units), with an ultimate completion date of August 25, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,920.26 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. The contract, awarded on December 17, 2025, carries a completion date of January 9, 2026 and employs firm fixed-price pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-count units) with a firm fixed price structure and an ultimate completion date of January 7, 2026. This non-set-aside competitive award represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract is valued at $4,380.39 and carries a firm fixed price structure with an ultimate completion date of January 8, 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CCNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets (30-count units) under a firm fixed-price contract. The award, issued on December 29, 2025, with an ultimate completion date of January 21, 2026, represents a competitively awarded non-set-aside procurement. Performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies primarily to military and veteran healthcare systems. The supply of ORGOVYX, a prescription medication, aligns with the company's demonstrated capability to deliver specialized pharmaceuticals across multiple therapeutic domains to support Department of Defense healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/28/25 |